SCHEMBL675015

SCHEMBL675015

Cc1cc(C2(C)CC(C)(C)c3c2cc(C)c(O)c3C)cc(C)c1O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.39
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
HNF4A P41235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377366 1.00 ACHE (0.39) ACHECA1CA2HNF4A
SCHEMBL6118523 0.87 ACHE (0.39) ACHECA1CA2HNF4A
SCHEMBL27963696 0.82 SENP1 (0.37) ACHE
SCHEMBL11058094 0.82 ACHE (0.43) ACHECA1CA2HNF4A
SCHEMBL11055114 0.82 ACHE (0.43) ACHECA1CA2HNF4A
SCHEMBL11055109 0.82 ACHE (0.43) ACHECA1CA2HNF4A
SCHEMBL11058089 0.82 ACHE (0.43) ACHECA1CA2HNF4A
SCHEMBL27963697 0.80 ACHE (0.35) ACHE
SCHEMBL10888216 0.77 ACHE (0.34) ACHEHNF4A
SCHEMBL6224833 0.74 HNF4A (0.50) ACHEHNF4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132240-A1 LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER SHPP GLOBAL TECH B V (NL) 2026-05-14 US disclosed
EP-3636692-B1 POLY(ARYLENE ETHER) COPOLYMER SHPP GLOBAL TECH BV (NL) 2026-04-29 EP disclosed
US-20260071103-A1 Anionic Curable Compositions DESIGNER MOLECULES INC (US) 2026-03-12 US disclosed
US-20260071104-A1 Anionic Curable Compositions DESIGNER MOLECULES INC (US) 2026-03-12 US disclosed
US-12503593-B2 Curable thermosetting composition including poly(arylene ether) copolymer SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2025-12-23 US disclosed
EP-3919545-B1 CURABLE THERMOSETTING COMPOSITION INCLUDING POLY(ARYLENE ETHER) COPOLYMER SHPP GLOBAL TECH BV (NL) 2025-10-22 EP disclosed
EP-3885392-B1 FUNCTIONALIZED POLY(ARYLENE ETHER) COPOLYMER, METHOD OF MAKING AND ARTICLES OBTAINED THEREFROM SHPP GLOBAL TECH BV (NL) 2025-07-02 EP disclosed
US-20250197542-A1 COPOLYMERS DERIVED FROM DICYCLOPENTADIENE SHPP GLOBAL TECH BV (NL) 2025-06-19 US disclosed
US-20250122328-A1 COPOLYMERS DERIVED FROM DICYCLOPENTADIENE SHPP GLOBAL TECNOLOGIES B V (NL) 2025-04-17 US disclosed
WO-2025058025-A1 RESIN COMPOSITION, CURED ARTICLE, PREPREG, METAL-FOIL-CLAD LAMINATE BOARD, RESIN COMPOSITE SHEET, PRINTED CIRCUIT BOARD, AND SEMICONDUCTOR DEVICE 三菱瓦斯化学株式会社 2025-03-20 WO disclosed
WO-2008089314-A1 FLAME RETARDANT POLY (ARLENE ETHER) COMPOSITIONS AND ARTICLES SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-07-24 WO disclosed
US-20080171817-A1 POLY(ARYLENE ETHER) COMPOSITIONS AND ARTICLES SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2008-07-17 US disclosed
EP-1940936-A1 POLYMER COMPOSITION, METHOD, AND ARTICLE General Electric Company (US) 2008-07-09 EP disclosed
WO-2008036454-A1 POLY (ARYLENE ETHER) COPOLYMER SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-03-27 WO disclosed
WO-2007044489-A1 FLAME RETARDANT COMPOSITION AND METHOD GENERAL ELECTRIC COMPANY (US) 2007-04-19 WO disclosed
WO-2007044294-A1 POLYMER COMPOSITION, METHOD, AND ARTICLE GENERAL ELECTRIC COMPANY (US) 2007-04-19 WO disclosed
WO-2007044312-A1 POLY(ARYLENE ETHER) COMPOSITION, METHOD, AND ARTICLE GENERAL ELECTRIC COMPANY (US) 2007-04-19 WO disclosed
US-20070082987-A1 Poly(arylene ether) composition, method, and article SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2007-04-12 US disclosed
US-20070082986-A1 Polymer composition, method, and article SABIC GLOBAL TECHNOLOGIES IP B.V. (NL) 2007-04-12 US disclosed
US-20070080330-A1 Flame retardant composition and method CITIBANK, N.A., AS COLLATERAL AGENT 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071104-A1 Anionic Curable Compositions VCL, ITGA8, GABRE ACHE 2078/4885CA1 1290/4885CA2 2415/4885
US-20260071103-A1 Anionic Curable Compositions CDH1, ESD, SETD2 ACHE 3046/4885CA1 1014/4885CA2 2476/4885
US-20260132240-A1 LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER CBLB, UBE4A, PSMD14 ACHE 1359/4885CA1 4064/4885CA2 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.